Intravenous immunoglobulin shifts microglial activation state toward anti-inflammatory activity and reverses beta-amyloid–mediated LTP inhibition

Eric Mohler, Arthur Nikkel, Richard Radek, Holly Robb, Michael Schrimpf, Jeffrey Waring, Chih-Hung Lee, Murali Gopalakrishnan, AbbVie Inc., North Chicago, Illinois, United States; AbbVie, North Chicago, Illinois, United States; AbbVie Inc., North Chicago, Illinois, United States; AbbVie Inc., North Chicago, Illinois, United States; AbbVie, North Chicago, Illinois, United States. Contact e-mail: robert.s.bitner@abbvie.com